Phase 2 Studies of Novel JAK1 Inhibitor for HS Show Promise
Use of a novel oral Janus kinase 1 inhibitor known as INCB054707 by patients with moderate to severe hidradenitis suppurativa (HS) produced rapid and dose-dependent […]
Read more